Comparison: Ozempic vs Wegovy
Both are reviewed at American Telehealth Review against published clinical evidence and FDA labeling.
Key differentiators
- Active ingredient: same (semaglutide), both Novo Nordisk.
- Indication: Ozempic is T2D-only; Wegovy is chronic weight management + CV risk reduction.
- Max dose: Ozempic 2.0 mg; Wegovy 2.4 mg.
- Cash price: Wegovy pen $349/mo through NovoCare self-pay (read October 15, 2026); Ozempic about $935/mo (May 2026 figure; not re-read).